About this trial
Although the theoretical model of "cyclic on-off switching of pulmonary blood flow" provides a crucial perspective for understanding VILI, its clinical validation and real-time intervention face significant obstacles. The fundamental reason lies in the lack of pulmonary microcirculation monitoring technology capable of bedside, non-invasive, continuous operation with sufficient spatiotemporal resolution. Nowadays, a novel 3D-EIT can perform real-time and non-invasive assessment of the distribution of pulmonary blood flow. However, if 3D-EIT can help to identify "cyclic on-off switching of pulmonary blood flow" is still unclear.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Adult patients with mechanical ventilation
diagnosis of moderate to severe ARDS no more than 72 hours
Disqualifiers
Chronic respiratory diseases that required long-term oxygen therapy, such as pulmonary fibrosis or chronical obstructive pulmonary disease
Contraindications to EIT (e.g., active implantable device, chest malformation, unstable spinal injuries or fractures, and open chest wounds)
Undrained pneumothorax or pneumomediastinum,
Hemodynamic instability
Trial population
Consecutive adult patients admitted to our ICU were screened for inclusion and exclusion criteria
Trial design
Case-crossover
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
The percent of "Cyclic On-Off Switching"
"Cyclic On-Off Switching" was assessed by 3D-EIT
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: